BONESUPPORT expanded its 2014 registry to include 230 CERAMENT™ G injectable bone substitute procedures, as well as those involving the CERAMENT V formulation.
BONESUPPORT established the registry in 1Q14 as part of the postmarket surveillance process for its antibiotic eluting injectable bone substitutes, like CERAMENT G with gentamicin. CERAMENT V includes vancomycin.
The CERAMENT G registry now includes 230 cases conducted in 18 hospitals across 9 countries. Procedures included in the registry address bone tumors, primary and revision hip and knee prostheses, osteomyelitis and the infected diabetic foot. Overall, the registry provides the ability to add more hospitals, more indications (like CERAMENT V) and more product line extensions, and is said to be among the most robust registries in the industry.
BONESUPPORT expanded its 2014 registry to include 230 CERAMENT™ G injectable bone substitute procedures, as well as those involving the CERAMENT V formulation.
BONESUPPORT established the registry in 1Q14 as part of the postmarket surveillance process for its antibiotic eluting injectable bone substitutes, like CERAMENT G with gentamicin....
BONESUPPORT expanded its 2014 registry to include 230 CERAMENT™ G injectable bone substitute procedures, as well as those involving the CERAMENT V formulation.
BONESUPPORT established the registry in 1Q14 as part of the postmarket surveillance process for its antibiotic eluting injectable bone substitutes, like CERAMENT G with gentamicin. CERAMENT V includes vancomycin.
The CERAMENT G registry now includes 230 cases conducted in 18 hospitals across 9 countries. Procedures included in the registry address bone tumors, primary and revision hip and knee prostheses, osteomyelitis and the infected diabetic foot. Overall, the registry provides the ability to add more hospitals, more indications (like CERAMENT V) and more product line extensions, and is said to be among the most robust registries in the industry.
Copy to clipboard 
